'Game Changer' Data for Vitamin D in Digestive Tract Cancers
New data reveal that vitamin D supplementation in a subgroup of patients with digestive tract cancer who are p53-immunoreactive may reduce their risk of relapse or death.
Stay updated with breaking news from I Malignancy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New data reveal that vitamin D supplementation in a subgroup of patients with digestive tract cancer who are p53-immunoreactive may reduce their risk of relapse or death.
The annual meeting of the American Society of Clinical Oncology (ASCO) will be bustling with 40,000 in-person attendees. Partnering with patients will be the core theme this year.
A machine-learning algorithm found that higher baseline symptom severity in older adults with advanced cancer was associated with a greater risk for unplanned hospitalization and death.
Survivors of childhood cancer who follow a healthy lifestyle may substantially reduce excess risk of later mortality from causes such as cancer and cardiovascular disease, suggests a new analysis.
Perhaps one of your patients could benefit from joining a clinical trial currently recruiting people with noncolorectal gastrointestinal cancers.